Biotech · Private company
iECURE, Inc.
Track this companyFree. Adds iECURE, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ECUR-506Phase 3 · Ornithine Transcarbamylase DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- No InterventionOrnithine Transcarbamylase DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)RECRUITING · started Dec 23, 2024ClinicalTrials.gov NCT06805695 · fetched Nov 12, 2026
- An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC DeficiencyPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 8, 2024ClinicalTrials.gov NCT06255782 · fetched Nov 12, 2026